Long-COVID mystery: new study aims to decode patient subtypes
NCT ID NCT07356570
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 150 adults with long-COVID to group them by their symptoms and link those groups to lab results. The goal is to find patterns that could help doctors predict outcomes and discover new treatments. Participants will have their health data and blood samples analyzed over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ACUTE COVID-19 SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Henry Gabrielle-HCL
RECRUITINGSaint-Genis-Laval, 69230, France
-
Service Pneumologie aigue spécialisée et cancérologie thoracique
RECRUITINGPierre-Bénite, 69 495, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Spirulina extract put to the test against long COVID inflammation
- Can brain training zap long COVID brain fog?
- Can tailored exercise help tame racing heart and fatigue after COVID?
- Brain training program aims to restore cognitive function in veterans with long COVID
- GP training may ease long COVID burden